CARDIFF ONCOLOGY, INC. Short-term Investments
CARDIFF ONCOLOGY, INC. (CRDF) had Short-term Investments of $25.32 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2026-08-11
- 2026-06-30: Short-term Investments $25.32M.
- 2026-03-31: Short-term Investments $37.51M.
- 2025-12-31: Short-term Investments $40.83M.
- 2025-09-30: Short-term Investments $50.46M.
| Period end | Short-term Investments |
|---|---|
| 2026-06-30 | $25.32M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $37.51M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $40.83M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $50.46M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $60.17M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $55.79M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $40.28M 10-K · filed 2026-02-24 |
| 2024-09-30 | $44.63M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $34.82M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $48.53M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $53.17M 10-K · filed 2025-02-27 |
| 2023-09-30 | $66.13M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $70.06M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $81.95M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $88.92M 10-K · filed 2024-02-29 |
| 2022-09-30 | $95.59M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $101.04M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $109.31M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $128.88M 10-K · filed 2023-03-02 |
| 2021-09-30 | $120.88M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $129.47M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $110.92M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 |
| 2018-06-30 | $31.50K 10-Q · filed 2018-08-03 |
| 2017-12-31 | $0.00 10-Q · filed 2018-08-03 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 |
| 2017-03-31 | $18.62M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $23.98M 10-K · filed 2018-02-26 |
| 2016-09-30 | $24.38M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $28.00M 10-Q · filed 2016-08-04 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |